Skip to search.
 STI Down0.09%

MannKind Corp. (MNKD)

-NasdaqGM

5.19 Up 0.03(0.58%) 18 May 04:00 SGT|After Hours : 5.18 Down 0.01 (0.19%) 18 May 07:43 SGT

Add to Portfolio
ProfileGet Profile for:
MannKind Corp.
28903 North Avenue Paine
Valencia, CA 91355
United States - Map
Phone: 661-775-5300
Fax: 661-775-2081
Website: http://www.mannkindcorp.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:246

Business Summary 

MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes and cancer in the United States. Its lead product candidate includes AFREZZA inhalation powder, an insulin that is in late-stage clinical investigation for the treatment of adults with type 1 or type 2 diabetes for the control of hyperglycemia. The company also develops MedTone and Dreamboat inhaler devices. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on MannKind Corp.

Key Executives 
 PayExercised
Mr. Alfred E. Mann , 87
Founder, Chairman and Chief Exec. Officer
853.00K0.00
Mr. Hakan S. Edstrom B.Sc., M.B.A., 63
Pres, Chief Operating Officer and Director
974.00K0.00
Mr. Matthew J. Pfeffer CPA, 55
Chief Financial Officer, Principal Accounting Officer and Corp. VP
565.00K0.00
Dr. Juergen A. Martens Ph.D., 57
Chief Technical Officer and Corp. VP of Technical Operations
592.00K0.00
Dr. David B. Thomson Ph.D., J.D., 46
Corp. VP, Gen. Counsel and Corp. Sec.
512.00K0.00
Amounts are as of Dec 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders